Abstract
The contrast-enhanced ultrasonography (US) study with intravenous administration of a contrast agent should be performed with the optimal technique under careful consideration of the characteristics of the contrast agent. In this chapter, we describe the contrast-imaging method using Levovist, the only contrast agent that has been approved under the Pharmaceutical Affairs Law in Japan.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kudo M: Contrast harmonic ultrasound is a breakthrough technology in the diagnosis and treatment of hepatocellular carcinoma. J Med Ultrasonics 2001; 28:79–81
Wen YL, Kudo M, Minami Y, et al: Contrast-enhanced Agent Detection Imaging: preliminary study in hepatocellular carcinoma. J Med Ultrasonics 2003 (in press)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Japan
About this chapter
Cite this chapter
Kudo, M. (2003). Agent Detection Imaging (ADI) (Acuson Sequoia 512). In: Contrast Harmonic Imaging in the Diagnosis and Treatment of Hepatic Tumors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-65904-4_13
Download citation
DOI: https://doi.org/10.1007/978-4-431-65904-4_13
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-65906-8
Online ISBN: 978-4-431-65904-4
eBook Packages: Springer Book Archive